Improved synthesis and biological evaluation of an acyclic thiosangivamycin active against human cytomegalovirus
- 1 July 1992
- journal article
- Published by Elsevier in Antiviral Research
- Vol. 19 (1) , 15-28
- https://doi.org/10.1016/0166-3542(92)90053-8
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Activity of acyclic halogenated tubercidin analogs against human cytomegalovirus and in uninfected cellsAntiviral Research, 1991
- Inhibition of Cell Growth and DNA, RNA, and Protein Synthesisin Vitroby Fentanyl, Sufentanil, and Opiate AnalgesicsBasic & Clinical Pharmacology & Toxicology, 1991
- Infectious Diseases Society of America and Centers for Disease Control: Summary of a Workshop on Surveillance for Congenital Cytomegalovirus DiseaseClinical Infectious Diseases, 1991
- AIDS-Related InfectionsScientific American, 1990
- Flow cytometric evaluation of the cytotoxicity of novel antiviral compoundsCytometry, 1990
- Synthesis, cytotoxicity, and antiviral activity of certain 7-[(2-hydroxyethoxy)methyl]pyrrolo[2,3-d]pyrimidine nucleosides related to toyocamycin and sangivamycinJournal of Medicinal Chemistry, 1989
- Synthesis, cytotoxicity, and antiviral activity of some acyclic analogs of the pyrrolo[2,3-d]pyrimidine nucleoside antibiotics tubercidin, toyocamycin, and sangivamycinJournal of Medicinal Chemistry, 1989
- Treatment of Serious Cytomegalovirus Infections with 9-(1,3-Dihydroxy-2-Propoxymethyl)Guanine in Patients with AIDS and Other ImmunodeficienciesNew England Journal of Medicine, 1986
- Growth Inhibition by Acycloguanosine of Herpesviruses Isolated from Human InfectionsAntimicrobial Agents and Chemotherapy, 1979
- [19] Cell cycle analysis by flow cytometryPublished by Elsevier ,1979